[144] Huron Consulting Group Inc. SEC Filing

Rhea-AI Filing Summary

Huron Consulting Group, Inc. (HURN) filed a Form 144 reporting a proposed sale of securities. The filing identifies 800 common shares to be sold through Fidelity Brokerage Services with an aggregate market value of $116,544 and notes approximately 17,306,887 shares outstanding. The approximate date of sale is listed as 10/01/2025. The filing also discloses the acquisition history for 300 shares (restricted stock vesting on 03/16/2011) and 500 shares (restricted stock vesting on 04/01/2015), both received as compensation. Recent executed sales during the prior three months are listed for the Niamogue Foundation and the John F. McCartney Trust on 07/01/2025, 08/01/2025 and 09/02/2025, each entry showing amounts and gross proceeds as provided in the filing.

Positive

• Clear disclosure of the proposed sale amount, market value, broker, and approximate sale date
• Acquisition history for the shares is provided, showing restricted stock vesting and compensation origin
• Recent sales by related trusts/foundation are itemized with dates and gross proceeds, supporting market transparency

Negative

• Insider-related sales are reported for multiple consecutive months, which some investors may view unfavorably
• Filing lacks issuer context such as reason for sales or any trading-plan adoption date under Rule 10b5-1

Insights

Securities Analyst

TL;DR: Routine Form 144 discloses proposed sale of 800 shares and recent related-party transactions; information appears procedural.

The filing documents a proposed sale of 800 common shares through Fidelity with an aggregate market value of $116,544 and an outstanding share count of 17,306,887. It also records prior restricted stock vesting dates and multiple recent sales by the Niamogue Foundation and the John F. McCartney Trust in July–September 2025 with the gross proceeds shown. From a trading-impact perspective, the filing is a standard Section 144 disclosure providing market transparency; it does not include operational or financial performance data.

Corporate Governance Expert

TL;DR: The notice documents insider-related sales and acquisition origins of the shares; disclosure meets Rule 144 transparency requirements.

The Form 144 identifies the seller's relationship to the issuer only in the context of reported transactions and supplies acquisition dates and the nature of acquisition (restricted stock vesting) for the shares to be sold. Recent sales by named trusts and a foundation are itemized with dates, quantities, and gross proceeds. The filing includes the signer’s compliance representation but contains no additional governance commentary or trading-plan dates.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	800	116544.00	17306887	10/01/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/16/2011	Restricted Stock Vesting	Issuer			300	03/16/2011	Compensation
Common	04/01/2015	Restricted Stock Vesting	Issuer			500	04/01/2015	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Niamogue Foundation 550 West Van Buren Street Chicago IL 60607	Common	07/01/2025	300	41022.00
John F. McCartney Trust 550 West Van Buren Street Chicago IL 60607	Common	07/01/2025	500	68370.00
Niamogue Foundation 550 West Van Buren Street Chicago IL 60607	Common	08/01/2025	300	38733.00
John F. McCartney Trust 550 West Van Buren Street Chicago IL 60607	Common	08/01/2025	500	64555.00
Niamogue Foundation 550 West Van Buren Street Chicago IL 60607	Common	09/02/2025	300	40863.00
John F. McCartney Trust 550 West Van Buren Street Chicago IL 60607	Common	09/02/2025	500	68105.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does HURN Form 144 report?

The filing reports a proposed sale of 800 common shares through Fidelity with an aggregate market value of $116,544 and an approximate sale date of 10/01/2025.

Who held the shares being sold according to the filing?

The filing shows the shares were acquired via restricted stock vesting on 03/16/2011 (300 shares) and 04/01/2015 (500 shares), recorded as compensation.

Were there recent related sales prior to this proposed sale?

Yes. The filing lists sales by the Niamogue Foundation and the John F. McCartney Trust on 07/01/2025, 08/01/2025, and 09/02/2025 with amounts and gross proceeds shown.

Which broker is handling the proposed sale?

The broker identified is Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI.

How many shares outstanding does the filing report?

The filing reports 17,306,887 shares outstanding for the issuer.